252 related articles for article (PubMed ID: 27886258)
1. A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth.
Viloria K; Munasinghe A; Asher S; Bogyere R; Jones L; Hill NJ
Sci Rep; 2016 Nov; 6():37839. PubMed ID: 27886258
[TBL] [Abstract][Full Text] [Related]
2. Embracing the complexity of matricellular proteins: the functional and clinical significance of splice variation.
Viloria K; Hill NJ
Biomol Concepts; 2016 May; 7(2):117-32. PubMed ID: 27135623
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of murine hevin (SC1), a member of the SPARC family of matricellular proteins.
Brekken RA; Sullivan MM; Workman G; Bradshaw AD; Carbon J; Siadak A; Murri C; Framson PE; Sage EH
J Histochem Cytochem; 2004 Jun; 52(6):735-48. PubMed ID: 15150282
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.
Esposito I; Kayed H; Keleg S; Giese T; Sage EH; Schirmacher P; Friess H; Kleeff J
Neoplasia; 2007 Jan; 9(1):8-17. PubMed ID: 17325739
[TBL] [Abstract][Full Text] [Related]
5. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
[TBL] [Abstract][Full Text] [Related]
6. Processing of the matricellular protein hevin in mouse brain is dependent on ADAMTS4.
Weaver MS; Workman G; Cardo-Vila M; Arap W; Pasqualini R; Sage EH
J Biol Chem; 2010 Feb; 285(8):5868-77. PubMed ID: 20018883
[TBL] [Abstract][Full Text] [Related]
7. Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.
Weaver M; Workman G; Schultz CR; Lemke N; Rempel SA; Sage EH
J Cell Biochem; 2011 Nov; 112(11):3093-102. PubMed ID: 21688302
[TBL] [Abstract][Full Text] [Related]
8. Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications.
Aroca-Aguilar JD; Sánchez-Sánchez F; Ghosh S; Fernández-Navarro A; Coca-Prados M; Escribano J
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):179-89. PubMed ID: 20926826
[TBL] [Abstract][Full Text] [Related]
9. Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons.
Mongrédien R; Erdozain AM; Dumas S; Cutando L; Del Moral AN; Puighermanal E; Rezai Amin S; Giros B; Valjent E; Meana JJ; Gautron S; Callado LF; Fabre V; Vialou V
Brain Struct Funct; 2019 Apr; 224(3):1219-1244. PubMed ID: 30656447
[TBL] [Abstract][Full Text] [Related]
10. SPARC, a matricellular protein: at the crossroads of cell-matrix.
Brekken RA; Sage EH
Matrix Biol; 2000 Dec; 19(7):569-80. PubMed ID: 11102747
[TBL] [Abstract][Full Text] [Related]
11. Follistatin-like protein 1 modulates IL-17 signaling via IL-17RC regulation in stromal cells.
Campfield BT; Eddens T; Henkel M; Majewski M; Horne W; Chaly Y; Gaffen SL; Hirsch R; Kolls JK
Immunol Cell Biol; 2017 Sep; 95(8):656-665. PubMed ID: 28377613
[TBL] [Abstract][Full Text] [Related]
12. SPARCL1 a novel player in cancer biology.
Gagliardi F; Narayanan A; Mortini P
Crit Rev Oncol Hematol; 2017 Jan; 109():63-68. PubMed ID: 28010899
[TBL] [Abstract][Full Text] [Related]
13. Roles of the synaptic molecules Hevin and SPARC in mouse neuromuscular junction development and repair.
Brayman VL; Taetzsch T; Miko M; Dahal S; Risher WC; Valdez G
Neurosci Lett; 2021 Feb; 746():135663. PubMed ID: 33493647
[TBL] [Abstract][Full Text] [Related]
14. SPARC-like 1 (SC1) is a diversely expressed and developmentally regulated matricellular protein that does not compensate for the absence of SPARC in the CNS.
Lloyd-Burton S; Roskams AJ
J Comp Neurol; 2012 Aug; 520(12):2575-90. PubMed ID: 22173850
[TBL] [Abstract][Full Text] [Related]
15. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
Puolakkainen PA; Brekken RA; Muneer S; Sage EH
Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression.
Chen G; Tian X; Liu Z; Zhou S; Schmidt B; Henne-Bruns D; Bachem M; Kornmann M
Br J Cancer; 2010 Jan; 102(1):188-95. PubMed ID: 19920824
[TBL] [Abstract][Full Text] [Related]
17. SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.
Kaleağasıoğlu F; Berger MR
World J Gastroenterol; 2014 Oct; 20(40):14747-59. PubMed ID: 25356037
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Pulmonary Bacterial Immunity by Follistatin-Like Protein 1.
Henkel M; Dutta JA; Partyka J; Eddens T; Hirsch R; Kolls JK; Campfield BT
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077624
[No Abstract] [Full Text] [Related]
19. Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis.
Barker TH; Framson P; Puolakkainen PA; Reed M; Funk SE; Sage EH
Am J Pathol; 2005 Mar; 166(3):923-33. PubMed ID: 15743803
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
